StockDrifts LogoStockDrifts

Kolon Tissue Gin 950160

Company
코오롱티슈진Kolon Tissue Gin
Insiders
2
Buys
2
Total Value
₩27M ($19K)
Avg Return
+177.31%
Last Filing
2026-05-12

Kolon Tissue Gin (950160) has 2 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩27M ($19K) in reported transaction value. The earliest filing StockDrifts holds for Kolon Tissue Gin is dated 2024-05-31; the most recent is 2026-05-12. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +177.31%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-08-06BUYMarket Buy
노문종
Noh Moon-jong
CEO582₩17,570+0.5%₩10M ($7K)
2026-07-27BUYMarket Buy
이규호
Gyuho Lee
Internal director2.6K₩15,910-18.3%₩42M ($29K)
2026-07-27BUYMarket Buy
김정인
Kim Jeong-in
Managing Director152₩15,910-18.3%₩2M ($2K)
2026-07-27BUYMarket Buy
전승호
Seungho Jeon
CEO646₩15,910-18.3%₩10M ($7K)
2026-05-12SELL교환
코오롱
cologne
--6.5K₩138,800+22.3%₩901M ($626K)
2026-05-08SELL교환
코오롱
cologne
--3.0K₩127,800+15.6%₩377M ($262K)
2026-03-25BUY제3자배정유상증자
코오롱
cologne
-118.0K₩102,300+24.1%₩12.1B ($8.4M)
2025-05-20BUYMarket Buy
권순욱
Soonwook Kwon
Managing Director200₩36,800+163.0%₩7M ($5K)
2025-05-19BUYMarket Buy
전승호
Seungho Jeon
CEO and President603₩33,200+191.6%₩20M ($14K)
2025-01-14BUY제3자배정유상증자
코오롱
cologne
-373.4K₩30,150+221.1%₩11.3B ($7.8M)
2024-07-05BUY행사가액조정
코오롱생명과학
Kolon Life Science
-874₩13,880+597.4%₩12M ($8K)
2024-05-31BUY제3자배정유상증자
코오롱
cologne
-762.4K₩14,260+578.8%₩10.9B ($7.5M)
2024-05-31BUY행사가액조정
코오롱생명과학
Kolon Life Science
-2.6K₩14,260+578.8%₩37M ($26K)

Frequently asked questions

Who has been buying Kolon Tissue Gin stock?
2 distinct insiders have filed 2 disclosed insider purchases in Kolon Tissue Gin (950160), most recently on 2026-05-12. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Kolon Tissue Gin have?
Kolon Tissue Gin has 2 buy-side and 0 sell-side disclosures on record, covering ₩27M ($19K) in total reported value, spanning 2024-05-31 to 2026-05-12.
Where does StockDrifts get Kolon Tissue Gin insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Kolon Tissue Gin. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.